Testicular cancer diagnosis and treatment statistics

Routes to diagnosis

'Two-week wait' is the most common route to diagnosing testicular cancer

Patient Experience

Testicular cancer patients rating their care very good or excellent, 2014, England

Almost 6 in 10 (55%) of testicular cancer cases in England are diagnosed via the ‘two-week wait’ referral route. This proportion is high compared with the average across all cancer types.[1]

Around a fifth (19%) of testicular cancer cases in England are diagnosed following a routine or urgent GP referral (but not under the ‘two-week wait’ referral route).[1]

Around a tenth (9%) of testicular cancer casesin England are diagnosed via an ‘other outpatient’ route (either through self referral, consultant to consultant referral or other type of referral).[1]

A tenth (10%) of testicular cancer cases in England are diagnosed after presenting as an emergency.[1] Almost half (48%) of emergency presentation cases are via Accident and Emergency (A&E), with the other cases coming via an emergency GP referral, inpatient referral or outpatient referral.[2]

There are variations in routes to diagnosis by sex, age, deprivation and ethnicity.[3]

Testicular Cancer (C62), Percentage of Cases by Route to Diagnosis, Adults Aged 15-99, England, 2012-2013

Last reviewed:

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly.

'31-day wait'

None of the countries in the UK meet the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat.[1-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

'62-day wait'

None of the countries in the UK meet the standard for their country on the percentage of patients receiving their first definitive treatment for cancer within two months of a GP referral for suspected cancer.[1-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Urological Cancers, Waiting Times, UK countries, 2014-15

    England England (testicular cancer only) Wales Scotland Northern Ireland
'14-day wait': seen by specialist following referral Performance 94.3% 97.0%      
Standard 93% 93%      
Performance against standard Meets standard Meets standard      
'31-day wait': receipt of first treatment following decision to treat Performance 95.3% 91.9% 94.0% 90.8% 89.7%
Standard 96% 96% 98% 95% 98%
Performance against standard Does not meet standard Does not meet standard Does not meet standard Does not meet standard Does not meet standard
'62-day wait': receipt of first treatment following referral Performance 78%   85.5% 85.9% 56.1%
Standard 85%   95% 95% 95%
Performance against standard Does not meet standard   Does not meet standard Does not meet standard Does not meet standard

Data for '14-day' and '31-day wait' in England also for testicular cancer separately.

References

  1. NHS England. Cancer waiting times.  Accessed May 2015.
  2. StatsWales. Cancer waiting times. Accessed May 2015. 
  3. ISD Scotland. Cancer Waiting Times. Accessed June 2015. 
  4. Department of Health, Social Services and Public Safety. Cancer Waiting Times. Accessed June 2015.
Last reviewed:

88% of testicular cancer patients rate their care as ‘excellent’ or ‘very good’.[1] Patient experience varies with individual needs and concerns, which are influenced by many aspects of personal background, disease characteristics and the care environment.

84% of patients were given the name of a Clinical Nurse Specialist in charge of their care.[1] Being given the name of a Clinical Nurse Specialist in charge of a patients’ care is the factor most likely to be associated with high patient satisfaction scores.[2]

69% said they saw their GP once or twice before being told they had to go to hospital.[1] How often a patient sees their GP before being referred to hospital varies by cancer type depending on ease of diagnosis.[3]

For testicular cancer the proportion that said they saw their GP once or twice before being told they had to go to hospital is higher than the average for all cancer patients.[1]

Spotting cancer early is important for improving survival so it is important that patients with potential cancer symptoms are referred for tests promptly.

Testicular Cancer (C62), Patient Experience Survey, Males, England, 2014

  Male
Percentage of patients treated for cancer who visited their GP once or twice about the health problem caused by their cancer 68.7%
Percentage of patients treated for cancer who said they were given the name of a Clinical Nurse Specialist in charge of their care 83.8%
Percentage of patients treated for cancer who rated their overall care as excellent or very good 87.9%

Last reviewed:

Cancer Statistics Explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Rate this page:

Currently rated: 2 out of 5 based on 1 vote
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page